Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,079 | -30,023 | -14,566 | -38,303 | -28,294 |
| Depreciation Amortization | 122 | 83 | 34 | 301 | 247 |
| Other Working Capital | 3,843 | 3,423 | 2,708 | 441 | -931 |
| Other Operating Activity | 6,220 | 3,955 | 1,778 | 7,468 | 5,663 |
| Operating Cash Flow | $-35,894 | $-22,562 | $-10,047 | $-30,093 | $-23,316 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -55,397 | -53,878 | -3,255 | -26,465 | -22,195 |
| PPE Investments | -86 | -25 | N/A | -7 | -7 |
| Sale Of Investment | 42,956 | 26,360 | 11,841 | 53,149 | 41,098 |
| Investing Cash Flow | $-12,527 | $-27,544 | $8,586 | $26,677 | $18,896 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,371 | 48,340 | 48,274 | 356 | 171 |
| Financing Cash Flow | $48,371 | $48,340 | $48,274 | $356 | $171 |
| Beginning Cash Position | 10,316 | 10,316 | 10,316 | 13,376 | 13,376 |
| End Cash Position | 10,265 | 8,550 | 57,130 | 10,316 | 9,128 |
| Net Cash Flow | $-51 | $-1,766 | $46,814 | $-3,060 | $-4,248 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,894 | -22,562 | -10,047 | -30,093 | -23,316 |
| Capital Expenditure | -86 | -25 | N/A | -7 | -7 |
| Free Cash Flow | -35,981 | -22,588 | -10,047 | -30,100 | -23,323 |